Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors

Cell Reports

Volumn 13, Issue 10, 2015, Pages 2147-2158

  Agarwal, Supreet ^a   Hynes, Paul G ^a   Tillman, Heather S ^a   Lake, Ross ^a   Abou Kheir, Wassim G ^a   Fang, Lei ^a   Casey, Orla M ^a   Ameri, Amir H ^a   Martin, Philip L ^b   Yin, Juan Juan ^a   Iaquinta, Phillip J ^c   Karthaus, Wouter R ^c   Clevers, Hans C ^d   Sawyers, Charles L ^c   Kelly, Kathleen ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HUBRECHT INSTITUTE   (Netherlands)

Author keywords

castration; heterogeneity; luminal; prostate cancer; stem progenitor cells

Indexed keywords

CD133 ANTIGEN; CD94 ANTIGEN; CD94F ANTIGEN; CYTOKERATIN; ENZALUTAMIDE; EPITHELIAL CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROMININ 1; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL SELF-RENEWAL; CLONAL VARIATION; CONTROLLED STUDY; CYTOPLASM; HISTOPATHOLOGY; IN VIVO STUDY; INFANT; LUMINAL PROGENITOR CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE TUMOR; PTEN GENE; STEM CELL; TP53 GENE; ADENOCARCINOMA; ANIMAL; CANCER STEM CELL; CELL LINEAGE; CELL SEPARATION; DISEASE MODEL; EPITHELIUM CELL; FLOW CYTOMETRY; KNOCKOUT MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

ADENOCARCINOMA; ANIMALS; CELL LINEAGE; CELL SEPARATION; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FLOW CYTOMETRY; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; NEOPLASTIC STEM CELLS; ORGANOIDS; PHENOTYPE; PROSTATIC NEOPLASMS;

EID: 84949579885     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.10.077     Document Type: Article

References (43)

1. Abou-Kheir, W.G., Hynes, P.G., Martin, P.L., Pierce, R., Kelly, K., Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model. Stem Cells 28 (2010), 2129–2140.
2. Blanpain, C., Fuchs, E., Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science, 344, 2014, 1242281.
3. Bonizzi, G., Cicalese, A., Insinga, A., Pelicci, P.G., The emerging role of p53 in stem cells. Trends Mol. Med. 18 (2012), 6–12.
4. Boutros, P.C., Fraser, M., Harding, N.J., de Borja, R., Trudel, D., Lalonde, E., Meng, A., Hennings-Yeomans, P.H., McPherson, A., Sabelnykova, V.Y., et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47 (2015), 736–745.
5. Chen, Z., Trotman, L.C., Shaffer, D., Lin, H.K., Dotan, Z.A., Niki, M., Koutcher, J.A., Scher, H.I., Ludwig, T., Gerald, W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005), 725–730.
6. Choi, N., Zhang, B., Zhang, L., Ittmann, M., Xin, L., Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21 (2012), 253–265.
7. Chua, C.W., Shibata, M., Lei, M., Toivanen, R., Barlow, L.J., Bergren, S.K., Badani, K.K., McKiernan, J.M., Benson, M.C., Hibshoosh, H., Shen, M.M., Single luminal epithelial progenitors can generate prostate organoids in culture. Nat. Cell Biol. 16 (2014), 951–961 1–4.
8. Cicalese, A., Bonizzi, G., Pasi, C.E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P.P., Pelicci, P.G., The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138 (2009), 1083–1095.
9. Gao, D., Vela, I., Sboner, A., Iaquinta, P.J., Karthaus, W.R., Gopalan, A., Dowling, C., Wanjala, J.N., Undvall, E.A., Arora, V.K., et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159 (2014), 176–187.
10. Giannico, G.A., Ross, H.M., Lotan, T., Epstein, J.I., Aberrant expression of p63 in adenocarcinoma of the prostate: a radical prostatectomy study. Am. J. Surg. Pathol. 37 (2013), 1401–1406.
11. Goldstein, A.S., Huang, J., Guo, C., Garraway, I.P., Witte, O.N., Identification of a cell of origin for human prostate cancer. Science 329 (2010), 568–571.
12. Humphrey, P.A., Histological variants of prostatic carcinoma and their significance. Histopathology 60 (2012), 59–74.
13. Karthaus, W.R., Iaquinta, P.J., Drost, J., Gracanin, A., van Boxtel, R., Wongvipat, J., Dowling, C.M., Gao, D., Begthel, H., Sachs, N., et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 159 (2014), 163–175.
14. Korsten, H., Ziel-van der Made, A., Ma, X., van der Kwast, T., Trapman, J., Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS ONE, 4, 2009, e5662.
15. Lee, D.K., Liu, Y., Liao, L., Wang, F., Xu, J., The prostate basal cell (BC) heterogeneity and the p63-positive BC differentiation spectrum in mice. Int. J. Biol. Sci. 10 (2014), 1007–1017.
16. Liu, Y.N., Abou-Kheir, W., Yin, J.J., Fang, L., Hynes, P., Casey, O., Hu, D., Wan, Y., Seng, V., Sheppard-Tillman, H., et al. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Mol. Cell. Biol. 32 (2012), 941–953.
17. Martin, P., Liu, Y.N., Pierce, R., Abou-Kheir, W., Casey, O., Seng, V., Camacho, D., Simpson, R.M., Kelly, K., Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am. J. Pathol. 179 (2011), 422–435.
18. Missol-Kolka, E., Karbanová, J., Janich, P., Haase, M., Fargeas, C.A., Huttner, W.B., Corbeil, D., Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate 71 (2011), 254–267.
19. Molyneux, G., Geyer, F.C., Magnay, F.A., McCarthy, A., Kendrick, H., Natrajan, R., Mackay, A., Grigoriadis, A., Tutt, A., Ashworth, A., et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7 (2010), 403–417.
20. Morrison, S.J., Spradling, A.C., Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132 (2008), 598–611.
21. Mulholland, D.J., Xin, L., Morim, A., Lawson, D., Witte, O., Wu, H., Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res. 69 (2009), 8555–8562.
22. Neubauer, B.L., Chung, L.W., McCormick, K.A., Taguchi, O., Thompson, T.C., Cunha, G.R., Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J. Cell Biol. 96 (1983), 1671–1676.
23. Ousset, M., Van Keymeulen, A., Bouvencourt, G., Sharma, N., Achouri, Y., Simons, B.D., Blanpain, C., Multipotent and unipotent progenitors contribute to prostate postnatal development. Nat. Cell Biol. 14 (2012), 1131–1138.
24. Peng, W., Bao, Y., Sawicki, J.A., Epithelial cell-targeted transgene expression enables isolation of cyan fluorescent protein (CFP)-expressing prostate stem/progenitor cells. Transgenic Res. 20 (2011), 1073–1086.
25. Pignon, J.C., Grisanzio, C., Geng, Y., Song, J., Shivdasani, R.A., Signoretti, S., p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc. Natl. Acad. Sci. USA 110 (2013), 8105–8110.
26. Rios, A.C., Fu, N.Y., Lindeman, G.J., Visvader, J.E., In situ identification of bipotent stem cells in the mammary gland. Nature 506 (2014), 322–327.
27. Robinson, D., Van Allen, E.M., Wu, Y.M., Schultz, N., Lonigro, R.J., Mosquera, J.M., Montgomery, B., Taplin, M.E., Pritchard, C.C., Attard, G., et al. Integrative clinical genomics of advanced prostate cancer. Cell 161 (2015), 1215–1228.
28. Roudier, M.P., True, L.D., Higano, C.S., Vesselle, H., Ellis, W., Lange, P., Vessella, R.L., Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum. Pathol. 34 (2003), 646–653.
29. Shah, R.B., Mehra, R., Chinnaiyan, A.M., Shen, R., Ghosh, D., Zhou, M., Macvicar, G.R., Varambally, S., Harwood, J., Bismar, T.A., et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 64 (2004), 9209–9216.
30. Shen, M.M., Abate-Shen, C., Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 24 (2010), 1967–2000.
31. Shibata, M., Shen, M.M., The roots of cancer: stem cells and the basis for tumor heterogeneity. BioEssays 35 (2013), 253–260.
32. Taylor, R.A., Wang, H., Wilkinson, S.E., Richards, M.G., Britt, K.L., Vaillant, F., Lindeman, G.J., Visvader, J.E., Cunha, G.R., St John, J., Risbridger, G.P., Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers. Stem Cells 27 (2009), 3032–3042.
33. Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Kaushik, P., Cerami, E., Reva, B., et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18 (2010), 11–22.
34. Toivanen, R., Berman, D.M., Wang, H., Pedersen, J., Frydenberg, M., Meeker, A.K., Ellem, S.J., Risbridger, G.P., Taylor, R.A., Brief report: a bioassay to identify primary human prostate cancer repopulating cells. Stem Cells 29 (2011), 1310–1314.
35. Toivanen, R., Frydenberg, M., Murphy, D., Pedersen, J., Ryan, A., Pook, D., Berman, D.M., Taylor, R.A., Risbridger, G.P., Australian Prostate Cancer BioResource. A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors. Sci. Transl. Med., 5, 2013, 187ra71.
36. Van Keymeulen, A., Rocha, A.S., Ousset, M., Beck, B., Bouvencourt, G., Rock, J., Sharma, N., Dekoninck, S., Blanpain, C., Distinct stem cells contribute to mammary gland development and maintenance. Nature 479 (2011), 189–193.
37. van Leenders, G., Dijkman, H., Hulsbergen-van de Kaa, C., Ruiter, D., Schalken, J., Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab. Invest. 80 (2000), 1251–1258.
38. Wang, Z.A., Shen, M.M., Revisiting the concept of cancer stem cells in prostate cancer. Oncogene 30 (2011), 1261–1271.
39. Wang, S., Garcia, A.J., Wu, M., Lawson, D.A., Witte, O.N., Wu, H., Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc. Natl. Acad. Sci. USA 103 (2006), 1480–1485.
40. Wang, X., Kruithof-de Julio, M., Economides, K.D., Walker, D., Yu, H., Halili, M.V., Hu, Y.P., Price, S.M., Abate-Shen, C., Shen, M.M., A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461 (2009), 495–500.
41. Wang, Z.A., Mitrofanova, A., Bergren, S.K., Abate-Shen, C., Cardiff, R.D., Califano, A., Shen, M.M., Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat. Cell Biol. 15 (2013), 274–283.
42. Xin, L., Lukacs, R.U., Lawson, D.A., Cheng, D., Witte, O.N., Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25 (2007), 2760–2769.
43. Zong, Y., Goldstein, A.S., Adaptation or selection–mechanisms of castration-resistant prostate cancer. Nat. Rev. Urol. 10 (2013), 90–98.